
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the companys proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspects bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases
Bioprinting,tissue engineering,regenerative medicine,and therapeutic development
Aspect biosystems operates in the Biotechnology research industry.
Aspect biosystems's revenue is 11m - 100m
Aspect biosystems has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.